Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Aber's quoted market is $2,361,612,954
divided by
TAH 648,896,346 shares
equals $3.64
divided by half (assuming they are half as good as Diavik's mine)
equals $1.82.
I pumped them up to $2.00-->$2.50 to round things off! (:
So, building a car around this engine is going to cost, how much more?
Another 20k, 30k, 40k?
A diesel electric generator that costs more than 20k.
Hmmmm!
Air conditioner, lawn mower?
Hmmmm!
Who is going to buy this for commercial use?
We need an engine that costs less than 2k!
Something affordable!
Any idea what this 42hp engine costs and can anyone buy one?
I meant $2.50 a share if they produce half the amount of diamonds the Diavik mine is currently producing.
They have not finished building the mines yet.
I would compare them to the Diavik mine by Aber TSX:ABZ
(only Canadian TSE listed producing mine)
which is hoovering at above $40.
Aber's quoted market (2,361,612,954)
value is 7.83 times
TAH quoted market value (301,736,801).
Aber has 57,670,646 shares
TAH has 648,896,346 shares
TAH is 11.25 times more shares than ABER.
If you divide ABER's quoted market value of
2,361,612,9 by TAH's total stocks 648,896,346
you get 3.64 per share.
From what I have read so far, TAH may be lucky to be half as good as the two current mines that are producing (Diavik & Ekati).
But they TAH seem to be accumalating lots of land and partners.
I think if they were producing diamonds right now, the max these shares would be at $5.00 per share.
And that's my Grade three Math.
I think $2.50 per share would be a good mine production price
maybe next year!
Can anybody come up with something better?
Be my guest!
Tahera Diamond Exploration yesterday announced it had entered into an agreement with Strongbow Exploration giving it the option to earn a 63.75% interest in the diamond rights to Strongbow's Tenacity South property.
Canadian metals explorer Wolfden Resources currently retains an option to earn up to a 60% interest in the gold and base metal rights to the property.
Tahera, based in Toronto, is moving towards a construction start on its wholly-owned Jericho Diamond Project, widely advertised by the company as "Nunavut's first diamond mine."
Huge Volumes on TSX:TAH
Tahera Diamond Corp. Price History for Symbol: TAH-T
Last: .460 Last Trade: Jan 25, 2005 16:26 EST
Date Close High Low Volume
Jan 25 0.460 0.480 0.450 5,060,800
Jan 24 0.470 0.470 0.450 3,600,900
Jan 21 0.445 0.445 0.435 1,984,400
Jan 20 0.440 0.455 0.435 4,521,100
Jan 19 0.435 0.435 0.420 6,636,400
Jan 18 0.425 0.440 0.420 3,455,000
Jan 17 0.435 0.435 0.410 3,201,700
TSX:RRE
OTCBB:RGUS
Expecting military results from Radian
http://www.regtech.com
http://www.investorshub.com/boards/board.asp?board_id=3122
http://www.investorshub.com/boards/board.asp?board_id=3156
Yeah, they came from Teck Cominco Ltd.
VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Jul 14, 2004) - Serengeti Resources Inc. (TSX-V SIR) is pleased to announce changes to the directors and officers of the Company and a financing for up to $150,000. These changes are designed to revitalize the Company's mineral exploration activities, including the installation of a senior explorationist as the Company's new president.
Management changes
Effective immediately, David W. Moore P. Geo., is appointed President and CEO, and a director. Mr. Moore has spent most of his 30 year career with Teck Cominco Ltd. and its business units Cominco Ltd., Cominco Resources International, and Cominco American Incorporated. Most recently, from 1999 to 2001 he served as General Manager of Global Exploration and from 2001 to 2003 as General Manager of Exploration Business Development. In addition to the preceding, Mr. Moore held a number of directorships of subsidiary companies. Mr. Moore has a proven track record of discovery and experience in both base and precious metals, ranging from grass roots exploration to feasibility and project development. Mr. Moore holds a M.Sc. in Geology from the University of Toronto and a P.Geo. designation in the Province of British Columbia.
Mr. George Tikkanen, P.Eng., is also appointed as a director of the Company. Mr. Tikkanen is a senior exploration and mining executive who held a number of significant positions before retiring from Cominco Ltd. in 1999. Mr. Tikkanen held the position of Vice-President Exploration, Cominco Ltd. from 1992 to 1998 and President of Cominco Resources International Limited, a publicly listed company, from 1987 to 1995. In the course of his career, Mr. Tikkanen was responsible for the management of eight mining operations in five countries and oversaw the discovery and acquisition of numerous mineral deposits including direct participation in the negotiations leading to the development of the Red Dog Mine in Alaska.
Further changes include the appointments of Ms. Sharon Fleming as Corporate Secretary and Mr. Myron Osatenko P. Geo., as a senior geological consultant to the Company. Mr. Ian Brown, formerly President of Serengeti will remain as a director and has agreed to serve as Chief Financial Officer. Mr. Tim Gallagher has agreed to step down as a director. The Board of Directors wishes to thank Mr. Brown and Mr. Gallagher for their service to the Company.
The Company announces the awarding of the following incentive stock options issued in accordance with the Company's option plan: to Mr. Moore, 600,000; to Mr. Tikkanen, 200,000; to Ms. Fleming, 50,000; and to Mr. Osatenko, 50,000. These options are exercisable at a price of $0.10 per share, expire on July 7, 2009 and vest over an 18 month time period. As part of these changes Mr. Brown has agreed to the cancellation of 183,000 options previously awarded to him. With these grants, the Company now has 1,930,000 shares optioned under its stock option plan.
I have been communicating with Doug Broadfoot,
Director, Clinical Sales and Marketing
E-mail dbroadfoot@responsebio.com
His response is that the U.S is their main focus, not Canada.
Can you believe that? We should all bombard him with emails protesting their line of thinking!
Come on people, demand an explanation!
--------------------------
Consumers
For questions about any of our products contact:
Monday to Friday 8:00 a.m. to 5:00 p.m. PST
Toll free in North America 1.888.591.5577
or 604.681.4101 Fax: 604.412.9830
Joanne Stephenson
Vice President of Business Development
E-mail jstephenson@responsebio.com
Sales and Marketing
Biodefense and Environmental Infectious Diseases
E-mail Sales
Doug Broadfoot
Director, Clinical Sales and Marketing
E-mail dbroadfoot@responsebio.com
Investors
Investors are encouraged to review the Company’s website where all publicly available information reported by the Company is available. For clarification, please contact:
Don Bradley
Director, Corporate Communications
Tel. 604.681.4101
E-mail dbradley@responsebio.com
To Order:
Mailing Address:
Response Biomedical Corp.
8081 Lougheed Highway,
Burnaby, B.C. V5A 1W9, Canada
Yes, I am. Have not come across anything recent about them.
How about you?
The original Volkswagon Beetle was air cooled. Nothing could kill that car. It was like a cockroach. You stamp on it and it crawls away and comes back again healthy for more.
A hybrid car or hybrid electric vehicle is a vehicle which relies not only on batteries but also on an internal combustion engine which drives a generator to provide the electricity and may also drive the wheels directly.
http://www.mywiseowl.com/articles/Hybrid_electric
Prior to its modern usage to mean hybrid propulsion, the word hybrid was used in the United States to mean a vehicle of mixed national origin; generally, a European car fitted with American mechanical components. This is falling out of use as the newer meaning gains more currency.
2004 Toyota Prius, a hybrid gas-electric vehicleOverview
A hybrid car uses more than one power source, almost always an internal-combustion engine and an electric motor. In the hybrid design, the combustion engine is the final source of the energy used to power the car, though an alternative motor assists when more power is demanded using stored energy. This contrasts with all-electric cars which use batteries charged by an external source. Benefits of the hybrid design include the following:
The vehicle is lighter and roomier than a purely electric vehicle of comparable size and power because fewer heavy batteries are needed.
The internal-combustion engine in a hybrid vehicle can be much smaller, lighter, and more efficient than the engine in a conventional vehicle, because the electric motor can provide a boost of power for acceleration.
Braking can be configured to recapture part of the kinetic energy of movement that would otherwise be wasted as heat in a conventional vehicle. This is called regenerative braking.
Most hybrid powertrains are characterized by a split power path called a powersplit. One side of this split is mechanical and the other side of this power path is electrical.
History
Hybrid technology actually originated with diesel-electric locomotives and diesel electric submarines. Both operate in essentially the same manner as hybrid electric cars.
The first successful hybrid electric car was engineered by Ferdinand Porsche in 1928. Since then, hobbyists have continued to build such cars but none was put into production by a major manufacturer until the waning years of the twentieth century.
Automotive hybrid technology became commercially successful in the 1990s when the Honda Insight and Toyota Prius became available. These vehicles have a direct linkage from the internal combustion engine to the driven wheels, so the engine can provide acceleration power. Prototypes of plug-in hybrid cars, with larger battery packs that can be re-charged from the power grid, have been built in the U.S., and one production PHEV, the Renault Kangoo, went on sale in France in 2003. DaimlerChrysler is currently building a small number of PHEVs based on the Sprinter van.
Earlier hybrid designs tended to use the electric motor for all power, due to simplicity. The engine would charge batteries from which the motor drew power, running only when needed to charge them back up. The engine would only run at its most efficient speed when doing so. However, this design was actually less efficient because of losses accrued in converting the kinetic energy of the engine into electrical energy, and back into kinetic energy at the wheels.
Recent developments
More modern designs reverse this to some degree, using the gasoline engine for primary power, but using one that is smaller than would otherwise be needed. The electric motor is essentially a very large starter motor, which operates not only when the engine needs to be turned over, but also when the driver "steps on the gas" and requires extra power. Instead of the engine solely charging the batteries, the motor acts as a generator during braking, using the momentum of the car to generate electricity. Thus the energy that would normally be lost when stopping is used to speed the car back up. Since the amount of electrical power needed is much smaller, the size of the battery systems is reduced.
Such designs were released in the late 1990s in the Honda Insight and Toyota Prius. The Insight sold poorly due to its high price and small size, but the Prius has been in high demand since its introduction. Newer designs are considerably more conventional and slightly cheaper, often appearing and performing identically to their non-hybrid counterparts while delivering 50% better fuel efficiency. The Honda Civic Hybrid appears identical to the non-hybrid version, for instance, but delivers about 50 mpg (US). The redesigned 2004 Toyota Prius improved passenger room, cargo area, and power output, while increasing energy efficiency and reducing emissions. The Honda Insight is still on sale and has a devoted base of owners, similar to the phenomenon observed with Apple computer.
2004 should see the first hybrid SUV's. Ford Motor Company is making the first hybrid SUV, the Ford Escape Hybrid. Toyota announced model year 2005 hybrid versions of the Toyota Highlander and Lexus RX 400h, and reportedly has plans to add hybrid drivetrains to every model it sells in the coming decades. Honda has also announced that they would release a hybrid version of the Accord.
An R.L. Polk & Co. Survey of 2003 automobiles showed that hybrid car registrations in the United States rose to 43,435 automobiles, a 25.8 percent increase from 2002 numbers. California had the most hybrid vehicles registered with 11,425, which may be partially due to its higher gasoline prices and emissions rules, which hybrids generally have little trouble passing.
Diesel
One particularly interesting combination uses a diesel engine for power. Diesels are excellent at delivering constant power for long periods of time, suffering less wear while delivering higher efficiency. However, the engines also suffer from poor acceleration due to having a limited RPM range. This poor acceleration can be addressed with the hybrid technique, and such designs may offer performance in a car of over 100 mpg (2.35 liter/100km).
Diesel hybrid have the advantage they can use 100% pure biofuels (biodiesel), so they don?t need petroleum at all.
However, there are no diesel production models as of 2003.
Battery technology
Because battery technology has not advanced dramatically enough to enable battery-only vehicles to have range on a single charge comparable to gasoline cars, and because major automakers have not been interested in marketing vehicles that have enough range for daily commuting and errands but not for interstate journeys, all major automakers involved in such research have since given up, and moved to fuel cells and hybrids. Toyota has announced that it intends that all its vehicles will have a hybrid electric version by 2012. It appears many European companies, where diesel is much more common, will follow Toyota's lead and move in the same direction.
Hybrid Types
In the earliest hybrid cars, prior to the Prius and Insight, the internal combustion engine only serves as an on-board generator to supply power to the electric motor which provide the sole driving force to the wheels. This is referred to as a "Series Hybrid" system.
In the second generation, the internal combustion engine drives the wheels directly with the electric motor serving as a power assist when extra power is needed, and to recapture the kinetic energy usually lost during braking. This is known as a "Parallel Hybrid" system. The extra power from the electric motor enables the manufacturers to reduce the engine size to achieve fuel economy. Either approach has its limitations.
Starting from 2004 model year, the Toyota Prius uses the third-generation hybrid design. In this new design, the wheels can be driven by either the internal combustion engine or the electric motor using a planetary gear system to draw power from either source. The on-board computer optimizes the fuel usage by shutting off the internal combustion engine when the electric motor is sufficient to provide the power. The internal combustion engine starts up whenever extra power is needed or the battery needs recharging. The electric motor serves as the main driving force and a generator. The more efficient new design enabled Toyota to build the new Prius as a mid-size car without sacrificing fuel economy.
Full hybrids
A "full hybrid", sometimes also called the "strong hybrid", is a vehicle that can run on just the engine, just the batteries, or a combination of both. The Prius and the Escape are examples of this. A large, high voltage battery pack is usually needed for battery-only operation.
Assist hybrids
Assist hybrids use a battery and electric motors to accelerate the car, but only in combination with the internal combustion engine. The Honda Insight is an example of an assist hybrid.
A variation on this type is Mazda's e-4WD system, offered on the Japan-market Mazda Demio. This front wheel drive vehicle has an electric motor which can drive the rear wheels when extra traction is needed. The system is entirely disengaged in all other driving conditions, so it does not enhance performance or economy.
Plug-In hybrids
These are full hybrids, able to run in electric-only mode, with larger batteries and the ability to recharge from the electric power grid (some call it griddable hybrid.) Their benefit is that they can be gasoline-independent for daily commuting, while they have the extended range of a hybrid for long trips. The Electric Power Research Institute's research indicates a lower total cost of ownership for PHEVs due to reduced service costs and gradually improving batteries. Some critics argue that unless the electric power is generated by clean energy source (such as solar, wind, hydro, geo-thermal etc.), a gasoline hybrid car may be cleaner and more energy efficient than a PHEV when the entire powerplant-to-tailpipe energy conversion cycle is considered.
Hydraulic hybrids
A hydraulic hybrid vehicle uses hydraulic and mechanical components instead of electrical ones. A variable displacement pump replaces the motor/generator, and a hydraulic accumulator replaces the batteries. The hydraulic accumulator, which is essentially a pressure tank, is potentially cheaper and more durable than batteries. Hydraulic hybrid technology is being actively developed by Eaton and several other companies, primarily in heavy vehicles like buses, trucks and military vehicles. Many cities, including New York City and Seattle, Washington have purchased hybrid electric/diesel buses.
Mild hybrids
There is another kind of cars that are marketed as hybrids, but technically they are not. The critics called these mild hybrid cars to distinguish from a real hybrid design. One upcoming example is the 2005 Chevrolet Silverado Hybrid fullsize pickup truck. Some people argue that it is not really hybrid since the electric motor/generator does not drive the wheels at all. In these mild hybrid cars, an oversize, large starter motor spins up the engine to operating rpm before fuel is injected into the combustion chambers. At high rpm, an engine can be restarted efficiently and cleanly. This allows the car to shut down the internal combustion engine whenever the car is coasting, braking, or stopped but the accessories can continue to run on electrical power. The motor/generator is also used to recapture energy through regenerative braking. Chevrolet was able to get a 10% improvement on the Silverado's fuel efficiency by shutting down and restarting the engine on demand. Mild hybrids often use 48 Volt systems to supply the power needed for the startup motor, as well as to compensate for the increasing number of electronic accessories on modern vehicles. These vehicles do not achieve the fuel mileage of "true" hybrid models.
Perks of owning a hybrid car in the US
Government agencies in the US offer benefits to encourage the purchase of certain qualifying hybrid or electrical vehicles.
The purchase of certain hybrid cars qualifies for a $2000 tax deduction on the IRS 1040 form for the year of 2003. The deduction reduces by $500 each year until it reaches zero. HR 1308 Sec. 319 proposed the phasing out of the deduction to put on hold for the year 2004 and 2005. i.e. hybrid car buyers can enjoy the $2000 deduction before the phasing out resumes at $500 in 2006.
Certain states give tax credits to hybrid car buyers.
Certain states, e.g. Virginia and Florida, allow singly occupied hybrid vehicles to enter the HOV lanes on the highway.
Certain states, e.g. California, exempt hybrid cars from the bi-annual smog inspection, which costs over US$50 in 2004.
Hybrid cars can go on certain toll roads for free.
City of San Jose, CA issues a free parking tag for hybrid cars that were purchased at a San Jose dealership. The qualified owners do not have to pay for parking in any city garage or road side parking meters.
City of Los Angeles, CA runs a six month experiment to offer free parking to all hybrid vehicles starting on Oct 1, 2004. The experiment is an extention to an existing offer of free parking for all electrical vehicle.
See also
Diesel-electric locomotive
Gas-electric hybrid engine
List of hybrid vehicles
Category:Hybrid vehicles
External links
http://www.hybridcars.com
How Hybrid Cars Work (http://www.howstuffworks.com/hybrid-car.htm) - Article from Howstuffworks.com
Ars Technica: 2003 Honda Civic Hybrid Car Review (http://www.arstechnica.com/reviews/02q3/civic-hybrid/2003-civic-hy-1.html)
MIT/Industry Consortium on Advanced Automotive Electrical/Electronic Components and Systems (http://mit42v.mit.edu/): Jumpstarting and Charging Batteries with the New 42V PowerNet.
Cambridge Chronicle article (http://www.townonline.com/cambridge/news/local_regional/cam_covccplanettranms04292004.htm) about an all-hybrid taxi fleet.
SHEP Technologies, Inc. (http://www.shepinc.com/) Hydraulic hybrids.
Hybrid Cars and Vehicles (MixedPower.com) (http://www.MixedPower.com/) By Hybrid Owners - For Hybrid Owners. A great place to research information on Hybrid Vehicles
Are Hybrid Cars Worth It? (http://www.smartmoney.com/consumer/index.cfm?story=20031126) Smartmoney.com says maybe not
The California Cars Initiative (http://www.calcars.org) Information about plug-in hybrid technology, prototypes, current efforts to convert Prius to become a plug-in hybrid
Toyota's paper on various hybrid designs (in PDF) (http://www.toyota.co.jp/en/tech/environment/hsd/pdf/a_guide_to_hsd.pdf)
Thanks for the link Stockey. But it still does not explain the connection with the Mazda engine. I brought this Rotary Engine discussion in the Hockey dressing room of 40 year old males with tons of technical experience and they waved this topic off as a done deal by Mazda's Rotary engine. I need more input.
Hopefully, by the time I am finished with this topic, I should have a real simple answer a dummy can understand.
Shikari, I have been to the website several times before my post. Have done a lot of research about engines but there is simply too much information on the Internet to siphon through. Your sending me back to the website is not going to help me or others that much if one is not comfortable in differentiating engines. I was simply asking for someone who knows (preferably a mechanic) to explain in simple layman's terms what the connection to the Mazda engine is. I still don't see the difference. Why is Mazda not on top of this Rotary Engine hype? They should be dominating the Car market.
Maybe I have not read enough. I have found that instead of reading endless information on the Internet, the chase can be cut if you ask the right people.If you know the answer, explain it in simple terms. It's just an engine, how hard could it be? But don't send me to read some website, because that's just like telling me to take a hike.
I have good money invested in this stock and it's jumping up and down not making sense to me. Your post probably stopped some knowlegible person from volunteering the layman's explanation I desperately need.
This technology sounds too good to be true!!
Why is this a penny stock? Don't make sense!!!!!!!!!!
Wether it works with Gas, Diesel, Propane, Natural Gas, Hydrogen..etc
Are the physical attributes of these engines the same?
They are both rotary engines, right?
Mazda has a rotary engine in some of their cars as per web page:
http://www.mazdarx8.co.uk/rotary/default.asp
Does anyone have an explanation for this?
Is there a link to RGUS/RRE?
Is RGUS/RRE getting royalties from MAZDA?
Hey Grandslam, feel free to post any news relavant.
Tiffany, the high-end US jeweller, has gone head-to-head with De Beers, announcing last week that it had struck a deal with miner Tahera to buy or market all the diamonds from its Jericho mine.
De Beers dominates the global rough diamond market, and other significant players in the value chain such as Israeli Lev Leviev the world's largest polisher, who supplies more than 10% of total rough production. T
ogether they maintain a degree of control over the global diamond mining, marketing, manufacturing and retail sales chain.
Analysts say although Tiffany's strategic move will not make it an immediate counterweight to De Beers, it does illustrate how De Beers' long-time grip on the marketing of rough diamonds is slipping."
De Beers polishes its approach to junior partners in Canada
--------------------------------------------------------------------------------
Diamond giant acts on criticism that it is slow and arrogant'
Antwerp Correspondent
RECENT comments made by junior mining companies in Canada suggest a different approach by De Beers as it grapples for market share.
Early last year a survey commissioned by De Beers' Canadian subsidiary was the talk of the town at the PDAC, the leading annual mining conference in Toronto.
Several participants said that the survey of junior mining companies' opinions on De Beers' approach to joint ventures and potential partners had concluded that the South African company was "slow, arrogant and inconsistent".
Other points of criticism included the slowness of De Beers' results and reports, that it did not always keep junior partners fully informed and that it sometimes deviated from the agreed action plan.
Several junior mining companies have now been promised an improvement in timely reporting, full transparency and a commitment that they will be full partners in the planning and decision making process. De Beers' market share has fallen below 50%.
"There is tremendous competition, it's a stock market-driven business, and you have to produce results to raise money," said the CEO of a prominent junior mining company in Vancouver.
"De Beers has already been looking for diamonds in Forte a la Corne (Canada) for more than 10 years."
Over the past nine months, De Beers Canada has been given the mandate from the De Beers Group to work freely with local partners to seal deals that fit the local market.
It has signed nine agreements with Canadian-listed exploration companies. To hasten p ossible production, De Beers has also doubled the capacity of its indicator mineral sorting laboratory in Toronto and upgraded some laboratories to cut turnaround times and improve the quality of sample reporting.
"De Beers Canada's new approach to joint ventures has been to encourage variety and originality in the deals transactions that can be negotiated quickly and simply," said spokeswoman Linda Dorrington.
"So far this is working fairly well, but the jury is still out on some issues," said one junior miner.
A key point with previous partnerships centred on the fact that De Beers would have the right to market all diamonds produced from a potential mine under what De Beers called a standard sales contract.
In all recent agreements, the partner becomes the operator and has the marketing rights, albeit up to a certain threshold.
For example, in a recent agreement with Tahera, involving projects of a defined value of 615m, Tahera will be the operator and have the marketing rights.
But for larger scale projects that prove economic, De Beers will be the operator and market the diamonds. While De Beers has been unable to bring a mine into production in Canada so far, it remains a powerful player with expertise.
"As a Canadian junior we really do see De Beers Canada as the partner of choice," said Robert Mc Callum at Kensington Resources.
"With their more than 100 years in the diamond business, state-ofthe-art technical facilities and experienced and competent people, they bring a world of reputation and credibility to any project."
De Beers currently has two mining projects in Canada.
Snap Lake, in the Northwest Territories, is set to go into full production in 2007 and is expected to produce between 150m and 200m annually.
De Beers is expected to make a decision on the development of the Victor project in northern Ontario by the middle of the year.
Bay Resources Announces Results from 2004 Exploration Projects at Committee Bay
TORONTO--(BUSINESS WIRE)--Jan. 4, 2005--Bay Resources Ltd, (OTCBB:BYRE), a Delaware Corporation specializing in gold exploration, announced today that it has completed its field component of the 2004 exploration program in the Committee Bay Greenstone Belt in Nunavut, Canada.
In mid May 2004, Bay Resources mobilized equipment and personnel to conduct regional and property scale exploration throughout its 100% owned claim groups in the highly prospective Committee Bay Greenstone Belt. A total of 1,576 samples were collected in a widespread sampling program designed to test all lithologic units over several project areas in the belt.
Highlights of the program include up to 100.4 gpt gold from a sulphide bearing iron formation on Bays' Wrench claims. The Wrench claim group comprise five contiguous claims covering approximately 4,900 hectares directly adjacent to Committee Bay Resources' ("CBR") Three Bluffs claim area. The Wrench claims are situated along strike of CBR's high grade iron formation where CBR have announced results of 24.8 grams per ton ("gpt") gold over 12.9 meters.
Of great interest are the results of a ground Horizontal Loop Electromagnetic (HLEM) and magnetic survey from a 176 line kilometer grid on the Wrench claims. The HLEM survey identified numerous high priority electromagnetic ("EM") conductors throughout the claims. In total, 17 EM conductive trends were identified. The majority of the conductors are associated with two prominent NE-SW strong linear magnetic trends; the north trend and east trend; associated with presence of iron formation. The geophysical survey was conducted by Aurora Geosciences Ltd.
Samples from the outcrop exposure along the western portion of the north trend reveal elevated gold values associated with iron formation for over 1 kilometer in strike length. Moving eastward, the outcrop exposure decreases, however, this strong "north trend" magnetic signature continues for more than 4 kilometers to the northeast.
Within the east magnetic trend, magnetite-quartz iron formation is observed immediately adjacent to a tonalite-sediment contact. In this region, two parallel magnetic highs are coincident with the strongest EM conductors on the grid. The east trend has a total strike length of approximately 2.4 kilometers and continues off the grid to the northeast.
Field work was conducted under the supervision of Bruce Goad, P. Geol., a Qualified Person under NI 43-101. Samples were analyzed with a 36 element geochemical procedure which included quality control/ quality assurance testing. Fire assays for gold were conducted where warranted. All samples were prepared and analyzed by Acme Analytical Laboratories Ltd.
The Wrench claims are one group of out several project areas that Bay Resources has throughout the Committee Bay Greenstone Belt, one of the world largest undeveloped greenstone belts.
About Bay Resources Ltd
Bay Resources Ltd is a Delaware corporation that is focussing its activities in the mining and exploration industry. Bay Resources has acquired a strategic land position in the highly prospective Committee Bay Greenstone Belt, Canada, for the purpose of undertaking gold and base metal exploration. Bay Resources has also entered into an arrangement with Tahera Corporation ("Tahera"), a Canadian diamond explorer, to explore for gold and base metals on Tahera's ground in the Slave Craton of northern Canada. Bay Resources is continuing to investigate opportunities in the industry for investment and or other types of participation. For further information please visit our website at www.bayresourcesltd.com.
Forward-Looking Statements
Forward-looking statements in this press release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, the risks of exploration and development stage projects, risks associated with environmental and other regulatory matters, mining risks and competition and the volatility of gold prices. Actual results and timetables could vary significantly. Additional information about these and other factors that could affect the Company's business is set forth in the Company's fiscal 2004 Annual Report on Form 10-KSB and other filings with the Securities and Exchange Commission.
News from Canada NewsWire
The Nunavut Water Board issues Jericho Diamond Project Water License for Ministerial Approval
09:30 EST Friday, December 24, 2004
TORONTO, Dec. 24 /CNW/ - Tahera Diamond Corporation announces that the Nunavut Water Board has issued the 'Class A' Water License for the Jericho Diamond Project.
The water license has been forwarded to the Minister of Indian and Northern Affairs Canada for approval. Tahera anticipates that the federal Minister will make a decision regarding approval of the water license within a 45-day period.
Tahera is currently finalizing land leases for both the Inuit owned land and crown land associated with the Jericho Diamond Mine, and expects to conclude this process in a timely fashion.
Both the water license and the land leases are required before Tahera can commence construction of the Jericho Diamond Mine. Tahera expects that it will attain all of the required approvals in sufficient time to utilize the 2005 winter road for project mobilization purposes.
About Tahera Diamond Corporation
Tahera Diamond Corporation (www.tahera.com) is a unique Canadian diamond Company focused on developing its wholly-owned Jericho Diamond Project as CANADA'S NEXT and NUNAVUT'S FIRST DIAMOND MINE. Tahera recently entered into an arrangement with Tiffany & Co., one of the world's leading jewelers, with respect to a diamond purchasing, marketing, and finance agreement for the Jericho Diamond Project. Tahera has several other very prospective diamond projects in Canada's prolific Slave Craton. The common shares of the Company trade on the TSX under the symbol 'TAH'.
/For further information: Tahera Diamond Corporation, R. Peter Gillin - Chairman and CEO; Grant Ewing - Executive Vice President, Corporate Development; Investor Relations: Tel: (416) 777-1998, Fax: (416) 777-1898, Toll free: (877) 777-2004, Email: investor_relations(at)tahera.com, Website: www.tahera.com/
The Nunavut Water Board issues Jericho Diamond Project Water License for Ministerial Approval
TORONTO, Dec. 24 /PRNewswire-FirstCall/ -- Tahera Diamond Corporation announces that the Nunavut Water Board has issued the 'Class A' Water License for the Jericho Diamond Project.
The water license has been forwarded to the Minister of Indian and Northern Affairs Canada for approval. Tahera anticipates that the federal Minister will make a decision regarding approval of the water license within a 45-day period.
Tahera is currently finalizing land leases for both the Inuit owned land and crown land associated with the Jericho Diamond Mine, and expects to conclude this process in a timely fashion.
Both the water license and the land leases are required before Tahera can commence construction of the Jericho Diamond Mine. Tahera expects that it will attain all of the required approvals in sufficient time to utilize the 2005 winter road for project mobilization purposes.
About Tahera Diamond Corporation
Tahera Diamond Corporation (www.tahera.com) is a unique Canadian diamond Company focused on developing its wholly-owned Jericho Diamond Project as CANADA'S NEXT and NUNAVUT'S FIRST DIAMOND MINE. Tahera recently entered into an arrangement with Tiffany & Co., one of the world's leading jewelers, with respect to a diamond purchasing, marketing, and finance agreement for the Jericho Diamond Project. Tahera has several other very prospective diamond projects in Canada's prolific Slave Craton. The common shares of the Company trade on the TSX under the symbol 'TAH'.
Quelle: Tahera Diamond Corporation
http://www.watchtowernews.org/randcam.htm
Lots of stuff about Rand Cam Engine on Internet.
Hey nlightn, doubloon can we compare stock picks.
you can email me at dimonfind@yahoo.ca
would like you to check out my favourites.
Sorry, looks like this board started on Nov 30.More people here!
I started one on Dec 13 when I first found out about the Canadian part on TSX:RRE see link below. Then this one started two days later.
http://www.investorshub.com/boards/read_msg.asp?message_id=4814152
Response Biomedical and 3M Collaborate on Infectious Disease Test
Monday November 29, 4:22 pm ET
VANCOUVER, Nov. 29 /PRNewswire-FirstCall/ - Response Biomedical Corp. (TSX-V: RBM - News) and 3M Company (NYSE: MMM - News) through its Medical Division, today announced that the two companies have entered into a co-development agreement whereby 3M will fund the development of a new rapid, point-of-care microbiology test in the area of infection prevention based on Response Biomedical's RAMP technology. The parties intend to enter into a further supply agreement whereby Response Biomedical will manufacture and 3M will exclusively market a line of microbiology tests.
"3M Medical Division is part of a world class company with an extraordinary ability to develop and commercialize promising new technologies," states Bill Radvak, President and CEO, Response Biomedical Corp. "This unique combination of technology and expertise in infectious disease testing will help us introduce a broader product portfolio to enhance patient outcomes and improve productivity for physicians and health care providers."
Conventional diagnosis of infectious diseases is time intensive, and prohibits immediate intervention and early treatment. Clinical infectious disease testing at the point-of-care is expected to improve patient outcomes by enabling physicians to make informed medical decisions rapidly.
About 3M:
3M is a diversified technology company with 2003 sales of more than $18 billion worldwide. 3M Health Care, the largest of seven major 3M businesses, is dedicated to improving the practice, delivery and outcome of care in medical, dental, pharmaceutical, health information and personal care markets. 3M Medical Division, part of the 3M Health Care family, is a leader in medical supplies, with expertise in infection prevention and skin health. For more information, visit www.3M.com.
About Response Biomedical:
Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP System for clinical and environmental applications, providing reliable information in minutes, anywhere, every time. RAMP represents a new paradigm in diagnostic testing, with the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. The RAMP System consists of a portable fluorescent Reader and single-use, disposable Test Cartridges. RAMP tests are commercially available for the early detection of heart attack, environmental detection of West Nile virus, and biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. The Company has achieved CE Mark and its Quality Management System is registered to ISO 13485: 1996 and ISO 9000: 2000.
Response Biomedical is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol "RBM". For further information, please visit the Company's website at www.responsebio.com.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. The statements made in this press release may contain certain forward-looking statements that involve a number of risks and uncertainties. Actual events or results may differ from the Company's expectations.
Contact:
Don Bradley Brian Korb
Director, Corporate Communications Senior Associate
Response Biomedical Corp. The Trout Group LLC
Tel: (604) 681-4101 ext. 202 Tel: (212) 477-9007 ext. 23
Email: dbradley@responsebio.com Email: bkorb@troutgroup.com
US Dept. of Homeland Security Sponsored Evaluation Confirms Superior Performance of Response Biomedical's RAMP(R) Anthrax Test
Wednesday November 10, 4:28 pm ET
Only RAMP Meets New Standards For Rapid Anthrax Detection
VANCOUVER, Nov. 10 /PRNewswire-FirstCall/ - Response Biomedical Corp. (TSX-V: RBM - News) today announced the Company's RAMP® Anthrax Test is the only rapid biological detection system to meet the new performance standards introduced by AOAC INTERNATIONAL for rapid immunoassay-based anthrax detection systems. Following rigorous independent evaluation, funded by the US Department of Homeland Security (DHS), the RAMP Anthrax Test is now laboratory tested and approved as both an AOAC Performance Tested Methods(SM) (PTM) and Official Methods of Analysis(SM) (OMA).
ADVERTISEMENT
"AOAC INTERNATIONAL uses a time tested and exceptionally rigorous process in evaluating analytical methodology. The RAMP system performed well in this rigorous evaluation, and that says quite a lot about it. AOAC and DHS are working rapidly to ensure that the RAMP System will be a very useful tool for first responders," stated E. James Bradford, Ph.D., Executive Director, AOAC INTERNATIONAL.
"We applaud DHS for commissioning a definitive evaluation and facilitating the introduction of prescribed performance standards to enable first responders to make informed purchasing decisions," states Bill Radvak, President and CEO, Response Biomedical Corp. "The broad publication of these results which unequivocally demonstrate RAMP's market-leading performance will ensure that emergency responders and corporate America have immediate access to the very best technology available, providing enhanced protection and peace of mind to millions of Americans, public safety personnel and corporations."
About the Task Force on Bacillus Anthracis, funded by the U.S. Department
of Homeland Security
--------------------------------------------------------------------------------
Shortly after September 11th terrorist attacks, the U.S. was faced with an outbreak of anthrax. Accurate and reliable methods were needed to detect B. anthracis in order to protect public health. The Department of Homeland Security recognized the need for an independent evaluation of these methods and in June 2003, partnered with AOAC INTERNATIONAL to fund the validation of existing methods for B. anthracis. A task force was formed that included representatives from industry, academia, and many government agencies to help in the selection of the methods and design of the studies.
Five rapid immunoassay-based anthrax field tests have undergone comprehensive validation through the AOAC harmonized Performance Tested Methods(SM) program, which provides an independent third-party review of test kit performance claims. RAMP has the exclusive designation of being the only commercially available system to meet the new standards for rapid and reliable anthrax detection.
In studies designed by AOAC scientists and implemented at U.S. Army Dugway Proving Grounds in Utah, RAMP was demonstrated to reliably detect Bacillus anthracis isolates representing a wide variety of geographic sources and physical variants. The specificity of RAMP was also demonstrated in evaluations to confirm that it would not cross react with non-Bacillus anthracis bacteria. To judge the accuracy of the data generated, AOAC organized 12 laboratories nationwide to assess RAMP's performance using identical samples. The RAMP test performed well in the collaborative study, and little variation was seen in the data produced by the 12 laboratories.
For more detailed information, please visit http://www.aoac.org/ILM/sept_oct_04/homeland_partners.htm
About AOAC INTERNATIONAL:
--------------------------------------------------------------------------------
AOAC INTERNATIONAL is a 120 year-old not-for-profit scientific association committed to worldwide confidence in analytical results. With more than 3700 members, AOAC has global brand recognition. The result of the work of AOAC communities, staff, and network of volunteers are AOAC® Official Methods(SM), the "gold standard" of methods accepted and recognized by regulatory agencies and organizations worldwide. In fact, many AOAC methods are specifically required in the enforcement of some state, provincial, municipal, and local laws and many federal food standards worldwide. For more information, please visit www.aoac.org.
About Response Biomedical:
--------------------------------------------------------------------------------
Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP System for clinical and environmental applications, providing reliable information in minutes, anywhere, every time. RAMP represents a new paradigm in diagnostic testing, with the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. The RAMP System consists of a portable fluorescent Reader and single-use, disposable Test Cartridges. RAMP tests are commercially available for the early detection of heart attack, environmental detection of West Nile virus, and biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. The Company has achieved CE Mark and its Quality Management System is registered to ISO 13485: 1996 and ISO 9000: 2000.
Response Biomedical is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol "RBM". For further information, please visit the Company's website at www.responsebio.com.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. The statements made in this press release may
contain certain forward-looking statements that involve a number
of risks and uncertainties. Actual events or results may differ
from the Company's expectations.
Contact:
Don Bradley Brian Korb
Director, Corporate Communications Senior Associate
Response Biomedical Corp. The Trout Group LLC
Tel (604) 681- 4101 ext. 202 Tel: (212) 477-9007 ext. 23
Email: dbradley@responsebio.com Email: bkorb@troutgroup.com
Nancy Broadbent
Media Liaison
AOAC INTERNATIONAL
Tel: (202) 250-8142
Email: nan0604@msn.com
Response Biomedical and Shionogi Collaborate on RAMP BNP Test For Congestive Heart Failure
Monday October 18, 8:32 am ET
VANCOUVER, BC, Oct. 18 /PRNewswire-FirstCall/ - Response Biomedical Corp. (TSX-V: RBM - News) today announced a collaboration with Shionogi & Co., Ltd to develop a rapid quantitative RAMP test for BNP (B-type natriuretic peptide), a proprietary cardiovascular marker test to assist in the diagnosis and management of congestive heart failure. Response Biomedical will develop the new RAMP BNP Test for Shionogi which has exclusive rights to BNP in Japan. Shionogi will fund development and will be responsible for regulatory affairs, marketing and distribution of the RAMP BNP Test in the Japanese market.
ADVERTISEMENT
"Having successfully completed the feasibility of the RAMP BNP Test, we are very excited to form a relationship with Shionogi, a leading Japanese pharmaceutical company. This development agreement for a BNP test is a significant first step in broadening the Company's clinical product portfolio with several new product candidates currently under evaluation in cardiovascular testing," states Bill Radvak, President and CEO. "We are very confident in our abilities to rapidly develop and commercialize a point-of-care BNP Test with lab quality performance to meet the needs of the Japanese medical community. We expect the point-of-care BNP Test will find strong market acceptance in Japan and enhance revenue from sales of the three FDA-cleared RAMP Cardiac Marker Tests."
About Congestive Heart Failure and BNP:
--------------------------------------------------------------------------------
Congestive heart failure (CHF) affects nearly 17 million people worldwide, and is the single most frequent cause of hospitalization in people over 65 years. According to the American Heart Association, approximately 5 million Americans are currently afflicted with CHF and 550,000 new cases are diagnosed each year. An estimated US$23.7 billion will be spent caring for current CHF sufferers. The prevalence of CHF is expected to continue increasing due to the aging population and improved survival rates of patients with other cardiovascular diseases.
Elevated levels of BNP indicate the presence of heart failure, and provide physicians with an important diagnostic tool in the early detection and management of CHF. The annual market for BNP testing is estimated to be US$500 million, with significant growth expected due to the increasing rate of adoption by the international medical community. BNP testing is gaining widespread acceptance as a routine procedure in the monitoring of patients with heart failure. Numerous clinical trials are exploring other cardiovascular applications, including acute coronary syndromes and heart surgery eligibility and prognosis.
BNP is secreted into the bloodstream by the heart in response to ventricular hypertrophy and pressure overload. BNP acts to relieve the pressure. The initial diagnosis of CHF is problematic as symptoms can be associated with other pathologies such as respiratory disease and the secondary effects of obesity. Clinical trials have demonstrated that rapid BNP testing in the emergency department can reduce hospital admissions, total treatment time and treatment costs. It has also been demonstrated that a single, point-of-care BNP Test performed immediately upon arrival at the emergency department provided greater diagnostic accuracy than a clinician using historical data, physical examinations, conventional laboratories and chest x-rays. For more information, please visit the US FDA website.
About Shionogi & Co., Ltd:
--------------------------------------------------------------------------------
Shionogi & Co., Ltd. (www.shionogi.co.jp), headquartered in Osaka, is one of the leading pharmaceutical companies in Japan. The Company recorded total net sales for fiscal year ended March 31, 2004 of approximately US$1.82 billion. Operating divisions are focused on pharmaceuticals, diagnostics, industrial chemicals and capsule business. Shionogi has marketed SHIONORIA BNP in Japan since 1994 as diagnostics and in Europe since 1997 as reagents for research use by medical doctors and laboratory investigators.
About Response Biomedical:
--------------------------------------------------------------------------------
Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP System for clinical and environmental applications, providing reliable information in minutes, anywhere, every time. RAMP represents a new paradigm in diagnostic testing, with the potential to be adapted to more than 250 medical and non-medical tests currently performed in laboratories. The RAMP System consists of a portable fluorescent Reader and single-use, disposable Test Cartridges. RAMP tests are commercially available for the early detection of heart attack, environmental detection of West Nile virus, and biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. The Company has achieved CE Mark and its Quality Management System is registered to ISO 13485: 1996 and ISO 9000: 2000.
Response Biomedical is a publicly traded company, listed on the TSX Venture Exchange under the trading symbol "RBM". For further information, please visit the Company's website at www.responsebio.com.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. The statements made in this press release may contain certain forward-looking statements that involve a number of risks and uncertainties. Actual events or results may differ from the Company's expectations.
Contact:
Don Bradley
Director, Corporate Communications
Response Biomedical Corp.
Tel (604) 681-4101 ext. 202
Email: dbradley@responsebio.com
Jonathan Fassberg
President
The Trout Group LLC
Tel: (212) 477-9007 ext. 16
Email: jfassberg@troutgroup.com
The Point of Care Diagnostic Testing World Markets Report Describes Products Segments That are Poised for a Major New Phase of Growth Fuelled by the Availability of New Technology
Monday October 4, 10:04 am ET
DUBLIN, Ireland, Oct. 4 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com ) has announced the addition of Point of Care Diagnostic Testing -- World Markets to their offering.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040820/RESEARCH )
This report examines of the worldwide Point of Care Diagnostic testing sector in a quantitative, business and market oriented treatment. Focusing on new technologies, new markets for near patient diagnostic products and new attitudes of patients and healthcare providers, this report is a sourcebook of data and analysis about the fastest growing sector of the $21 billion worldwide diagnostic industry whose products are transforming the practice of medicine.
The Point of Care Diagnostic Testing World Markets report describes products segments that are poised for a major new phase of growth fuelled by the availability of new technology platforms an the demand for more efficient medical service.
Near patient tests, including those for blood glucose, pregnancy, ovulation, coagulation, cholesterol, drugs, infectious disease and various urine components, are in high demand as physicians and patients realize their potential for promoting improved health care.
The POC market for diagnostic tests in the United States increased at a phenomenal compounded annual growth rate, and many parts of the world market grew at comparable rates, with Germany as the leader in Europe and high rates of growth in rest of the world including Asia and Japan. This report examines market sizes and growth rates for important country markets in Europe and Asia, including China.
This report examines the three basic factors have driven the market for Point of Care diagnostic testing products, and looks at the POC market's two general segments: the hospital market and the physician's office. The POC market encompasses a large variety of IVD products ranging from moderate sized instrumented diagnostic systems serving larger institutional uses to single- use, disposable tests for individual home use.
This report discusses Point of Care Diagnostic product industry trends that are believed to influence POC testing, including demographic changes, reimbursement policies, regulations, and the availability of clinically valuable tests that will increase growth in this diagnostic category. Detailed discussions of regulatory requirements for point of care diagnostic products for the U.S., Japan, and the EU are presented.
The report also includes discussions of Competitive Outlook, and Market Strategies. It also covers specific at point of care testing areas such as Glucose Monitoring, Pregnancy Testing, Hepatitis Testing, Drugs of Abuse Screening Testing, Infectious Disease Testing, HIV, Coagulation Testing and Fertility Testing.
There is also an important discussion of the emerging technologies for point of care diagnostics and the implications of molecular biology and genomics for new rapid diagnostic tests. Exiting new technology areas such as Protein Sequencing, DNA Sequencing and The Human Genome Project are placed into the context of their impact on rapid diagnosis.
Market Trends and Forecasts in point of care diagnostics such as the move to electro-detection for rapid glucose analyzers, Mergers and Acquisitions of Diagnostic Companies, emerging rapid tests for infectious disease, Rt-pcr, new cardiac monitors and more are reported in detail, and the strategies of the key industry players is discussed.
Finally, this report summarizes the business developments of over 100 companies from all parts of the world that market and manufacture point of care diagnostic products. Key merger and acquisition data are included.
The Point of Care Diagnostic Testing World Markets report is constantly updated, so that all important developments throughout the current year are included in the report.
This report provides not only the factual details of the rapid diagnostic testing segment, but answers, "why it is significant" and "what does it mean for your company". A leading expert in diagnostic testing and marketing wrote the report.
1. Overview
2. Introduction
3. Point of Care Testing: Market Segment Analysis: Size, Growth, Share
4. Point of Care Testing: Reagents and Equipment
5. Point of Care Testing: Hospital Issues
6. Business Trends In The Industry
8. Corporate Profiles
-- Abaxis
-- Lifescan Inc.
-- Orasure
-- Bayer
-- Nova
-- Savyon Diagnostics
-- Spectral Diagnostics Inc.
-- Biosite Diagnostics
-- Abbott Laboratories
-- Instrumentation Laboratories
-- MedMira Laboratories
-- Diametrics Medical Inc.
-- Radiometer
-- Chiron Diagnostics
-- Gen Bio
-- Ely Labs
-- Orgenics
-- BioMerieux Vitek, Inc.
-- Cortec Ltd.
-- Ani Biotech
-- Sybron International Corporation
-- Optical Sensors Inc.
-- Worldwide Medical
-- International Medical Inovations
-- Cardiovascular Diagnostics Inc.
-- Abaxis Inc.
-- Carter-Wallace Inc.
-- Chemtrak Inc.
-- Cholestech Corp.
-- Hemocue Inc.
-- Binax
-- Selfcare Inc./Inverness Medical
-- Johnson & Johnson
-- Accumetrics, Inc.
-- First Medical, Inc.
================================================================
-- Response Biomedical Corp.
================================================================
-- Compucyte Corporation
-- Caliper Technologies
-- Diagnostic products Corporation
-- Murex Corporation
-- Princeton BioMeditech Corp.
-- American Biogenic Sciences
-- New Horizons Diagnostics
-- Beacon Diagnostics
-- Saliva Diagnostics
-- Calypte Biomedical
-- Meridian Diagnostics
-- Quidel
-- Biomerica
-- Diagnology
-- Biostar
-- Actimed Diagnostics
-- Empyrean Diagnostics
-- S.T.C. Technolgies
-- Trinity Diagnostics
-- Genzyme Diagnostics
-- ImmunoScience
-- Cygnus Therapeutic Systems
-- Seradyn Clinical Diagnostics/Apogent
-- Adeza Biomedical Corporation
-- Array Medical
-- TransMedica
-- Bioscan, Inc.
-- American Bio Medica Corp.
-- GDS Diagnostics
-- Home Access Health Corp
-- Pharmatech Corporation
-- Thoratec/International Technidyne Corp
-- Int'l Immunodiagnostics
-- Avocet Medical
-- SpectRx, Inc
-- Helena Laboratories
-- Technical Chemicals & Products
-- Roche Diagnostics
-- Simplex Medical Systems
-- Biex Inc.
-- Point of Care Technologies
-- LXN Corp (Inverness Medical Technology)
-- American Biogenetic Sciences, Inc.
-- Lifestream Diagnostics
-- PanBio Corp
-- Phillips Medical Systems
-- Jiangnan Biotech. Co., Ltd.
-- Minimed, Inc
-- Meretek Corporation
-- AVOX Systems
-- Dade Behring
-- Chongquing Sungene Pharmaceutical Co.
-- Medical Services International
-- Therasense, Inc.
-- Pharmanetics
-- Kehua Biotech
-- LifePoint, Inc.
-- Avitar
-- Cozart Biosciences
-- Enterix, Inc.
-- Kyowa Medex Co., Ltd.
-- Iatron
-- Denka Seiken Co., Ltd.
-- Accurex Biomedical, Pvt., Ltd.
9. Market Trends & Forecasts
10. Corporate Directory
For more information visit http://www.researchandmarkets.com/reports/c5753
Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980
Rimfire Announces Nevada Exploration Alliance with Newmont
VANCOUVER, British Columbia--(BUSINESS WIRE)--Dec. 15, 2004--David Caulfield, President and CEO of Rimfire Minerals Corporation (TSX VENTURE:RFM) is pleased to announce the creation of an exploration alliance with Newmont Capital Limited, a subsidiary of Newmont Mining Corporation (NYSE:NEM) targeting a defined project area of 3060 square miles (7920 sq. km) in Nevada's Walker Lane Mineral Belt.
"The invitation to work in the State of Nevada with Newmont, one of the world's premier gold companies, is very exciting," said David Caulfield. "The agreement capitalizes on the complementary assets and technical skills of both companies. We look forward to finding new gold projects for our shareholders and also creating opportunities for Newmont by unlocking the value of their extensive Nevada database."
Rimfire will have access to Newmont's geological, geochemical and geophysical databases for the defined area. Newmont has agreed to provide dedicated technical assistance and use of its proprietary target compilation "neural network" technology.
According to M. Stephen Enders, Vice President Worldwide Exploration for Newmont, "Greenfield exploration is the foundation of our industry, and top-quality personnel are critical to that process. I am confident that Rimfire has the creative geoscience talent to efficiently maximize the value of our exploration opportunities."
Rimfire has committed to making USD$300,000 in expenditures within the project area during the term of the two year agreement. Rimfire may, at its discretion, acquire one or more properties within the project area boundaries in which to conduct further exploration work. On Rimfire's acquisition of any property interest, Newmont will be granted a Net Smelter Return Royalty of 2.0% to 3.0% on a sliding scale based on the price of gold.
Newmont will have a one-time right to enter a 50:50 Joint Venture upon Rimfire expenditures of USD$300,000 on an acquired property. When this right is exercised, Newmont will relinquish the Net Smelter Return Royalty, manage the Joint Venture, and solely fund the next USD$1,000,000 in exploration to earn its 50% interest.
Rimfire Minerals Corporation is an aggressive, well-financed mineral exploration company with a portfolio of highly prospective gold and silver properties in western North America. Partners include Newmont Mining Corporation, AngloGold (U.S.A.) Exploration Inc., Northgate Minerals Corporation, Cangold Limited, and Serengeti Resources Inc.
On behalf of Rimfire Minerals Corporation
David A. Caulfield, President
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Rimfire Minerals Corporation (TSX VENTURE:RFM)
Serengeti Locates Gold-Silver Showing on Twin Property
VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Dec. 7, 2004) - Serengeti
Resources Inc. (TSX VENTURE:SIR) David W. Moore, President and CEO of
Serengeti Resources Inc., is pleased to announce that the Company has
located a surface showing with elevated gold-silver values on the Twin
property. Twin is located on the Granduc Mine road, 32 kilometers north
of Stewart and four kilometers south of the Tide property where
Serengeti and partner Rimfire Minerals Corporation recently announced
the discovery of a very high grade gold-silver surface showing (values
up to 593 g/t Au and 14708 g/t Ag), as well as a drill intercept grading
1.0 g/t gold over 129.4 meters in a separate zone (see News Releases
dated November 23 and November 28, 2004).
The highlight of the exploration program conducted on the Twin property
in 2004 was the location of two old trenches, 15 meters apart, which
returned values in chip samples of 11.5 g/t gold, 93 g/t Ag over 1.7
meters and 11.6 g/t gold, 141 g/t silver over 3 meters. This
mineralization is associated with an east-west trending silicified zone
containing minor arsenopyrite, galena and sphalerite. Soil sampling
during the course of the recent program, 75 meters down slope of these
trenches, outlined a strong gold-arsenic-silver anomaly at least 125
meters wide which is unlikely to be solely caused by the mineralized
zone located to date. Sampling elsewhere on the 7.5 square kilometer
Twin property returned values from trace to 0.71 g/t gold in 15 rock
samples. Limited stream sediment geochemical sampling during the course
of the recent program also identified an anomalous drainage containing
166 parts per billion gold, from an area one kilometer to the south of
the mineralized trenches. Twin is one of a portfolio of five properties
in which Serengeti may earn a 100% interest (see News Release dated July
8, 2004).
The vein style of mineralization located to date at Twin is similar in
character to that at the formerly producing Snip gold mine (one million
ounces total production); or to the formerly producing Scottie gold mine
located one kilometer to the west of Twin; and to the recently announced
high grade gold-silver surface discovery on the Tide property.
Follow-up of these encouraging results as well as prospecting of a
geological horizon on the eastern side of the Twin property believed to
be age equivalent to the rocks hosting the Eskay Creek gold-silver
deposit is planned for the 2005 field season.
Analytical results from the current program were completed at ALS Chemex
in North Vancouver, BC. The technical information in this news release
has been prepared in accordance with Canadian regulatory requirements
set out in National Instrument 43-101 and reviewed by the Company's
qualified person David W. Moore, P.Geo., President and CEO of Serengeti
Resources Inc.
Serengeti is a mineral exploration company under experienced new
management who bring a solid track record of discovery. Serengeti is
focused on discovery copper-gold and gold-silver deposits in British
Columbia, especially in the highly prospective Quesnel Trough and
Stewart mining camps.
Is the content on television any diffferent from what the company has on their website? Have not been able to see the show yet! Maybe someone can copy, digitise and post on a website?
Or perhaps email?
Ok, I kind of over-exaggerated about the "losing house scene".
But I did buy more than I should have only because I am in the technical field and can recognise this company's potential.
I would be interested in your picks like stockey says.
Is there some way of finding out your favourites?
Maybe we can start a "My Favourites Board" and share stock picks!
Who is game?
Doubloon and nlightn, I have been told that when a stock continue to increase in value for consecutive days, a correction happens abruptly like it did on Friday when this stock opened at $1.05 and then quickly drops in value like it did to .62 cents.
Can anyone clarify this? Is this what really happens? I still like this stock because it looks like a real jewel but I don't want to lose my house!
TAHERA CLOSES US$2.44 MILLION FINANCING
December 20, 2004
Canadian diamond company Tahera Diamond Corporation has closed the previously announced private placement of flow-through common shares, resulting in the issue of 6,666,667 flow-through common shares at a subscription price of US$0.37 per share, for gross proceeds of US$2.44 million.
Tahera will utilize the proceeds from the private placement to fund a portion of its 2005 exploration activities on its diamond projects in Nunavut and the Northwest Territories.
Hello Doubloon, where are you getting your info from? Can you post some links please?